Stock Analysis of Odonate Therapeutics (ODTC) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ODTC
Close 2849.50
Change -14250.50 / 83.34 %
Volume 2.00
Vol Change 1.00 / 100.00 %
IndustryShell Companies
SectorFinancial Services
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Low Growth Stock
Value Index Very Low Value Stock
Profitability Index Very Low Profitability Stock
Stability Index Good Stability


Fundamental View of Odonate Therapeutics


Highs/Lows of Odonate Therapeutics
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week3500.0 18.59 % 1.54 % 17100.02849.507-May-2409-May-24
Two Week3500.0 18.59 % 3.42 % 17100.02849.507-May-2409-May-24
One Month3500.0 18.59 % 5.60 % 17100.02849.507-May-2409-May-24
Three Month1.5 189866 % 5.95 % 17100.02849.507-May-2409-May-24
Six Months1.5 189866 % 17.48 % 17100.02849.507-May-2409-May-24
One year1.8 158205 % 27.52 % 17100.01.507-May-2407-Sep-23
Two year1.4 203435 % 29.70 % 17100.00.80807-May-2401-Aug-22
Five year20.68 13679.01 % 85.46 % 17100.00.80807-May-2401-Aug-22


Technical View of Odonate Therapeutics






Charts of Odonate Therapeutics


Returns of Odonate Therapeutics with Peers
Period / StockODTCCONXTGVCKINZAIHS
1 Week-18.59%-48.81%-1.91%375.33%12.50%
1 Mth-18.59%-57.43%-3.56%-19.16%11.11%
3 Mth189866%-57.55%-0.552%-29.49%14.65%
6mth189866%-57.22%1.89%-28.84%303.59%
1 Year158205%-56.08%4.55%-29.20%1.69%
2 Year203435%-54.31%9.19%-28.34%-8.63%
5 Years13679.01%----97.75%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Odonate Therapeutics with Peers
Ratio / StockODTCCONXTGVCKINZAIHS
PE6810.48-31.62-21.796.79-1.60
P/B589.7490.010.8072.200.942
ROA6.96-6.50-3.5529.48-33.23
ROE8.660-10.140-95.82
Debt To Equity0.0047-0.1170-0.0940.109
Revenue0
%
0
%
0
%
8470.00 K
%
8082.51 K
64.51 %
Net Income7325.00 K
82.94 %
-1749.99 K
107.23 %
-2380.65 K
177.62 %
17634.91 M
191419 %
-3113.75 K
480.25 %


Technicals of Odonate Therapeutics with Peers
Technical / StockODTCCONXTGVCKINZAIHS-
ADX62.2234.4620.6928.0925.34
CMF-0.055-0.4040.2420.215-0.0295
MFI77.9852.2233.4099.7385.39
RSI51.681.5844.7967.3754.33
MACD Abv SignalTrueFalseFalseTrueTrue
Price Above 50 MATrueFalseFalseTrueTrue-
Price Above 200 MATrueFalseTrueFalseTrue-


About : Odonate Therapeutics


Address : 3 East 28th Street, New York, NY, United States, 10016
Tel : 332 206 0935
URL : https://www.odonate.com
Code : ODTC, ISIN : US6760791060, Exchange : PINK, Country : USA
Fiscal Year End : December
IPO date : 07_Dec_2017
Employee Count : 137

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.


Note : All Data Generated at the End of Trading Hours (EOD Data)